Cargando…

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. To date, six large randomized controlled clinical trials on the efficacy of pharmaceutical treatment in GIOP have been conducted. All of these studies have focused predominately on bone mineral density outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adami, Giovanni, Rahn, Elizabeth J, Saag, Kenneth G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755635/ https://www.ncbi.nlm.nih.gov/pubmed/31565078 http://dx.doi.org/10.1177/1759720X19876468

Ejemplares similares

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy
por: Taylor, Adam D, et al.
Publicado: (2019)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Glucocorticoid-induced osteoporosis: an update
por: Compston, Juliet
Publicado: (2018)

Update on Glucocorticoid Induced Osteoporosis
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015
por: Yeap, Swan Sim, et al.
Publicado: (2017)

Glucocorticoid‐induced osteoporosis in rheumatic diseases
por: Pereira, Rosa Maria Rodrigues, et al.
Publicado: (2010)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Zebrafish models for glucocorticoid-induced osteoporosis
por: Lin, Wen-Ying, et al.
Publicado: (2022)

Depressive Symptoms and the Effectiveness of a Urate‐Lowering Therapy in a Clinical Trial
por: Mrug, Sylvie, et al.
Publicado: (2020)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
por: Peng, Cheng-Huan, et al.
Publicado: (2021)

Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Mechanisms of glucocorticoid induced osteoporosis
por: Canalis, E
Publicado: (2004)

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial
por: Saag, Kenneth G., et al.
Publicado: (2019)

Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective
por: Yamasaki, Satoshi
Publicado: (2023)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials
por: de Quervain, Dominique, et al.
Publicado: (2019)

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
por: Payer, Juraj, et al.
Publicado: (2010)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Linking glucocorticoid-induced osteoporosis to osteoimmunology
por: von Gunten, Stephan, et al.
Publicado: (2020)

Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis
por: Zhou, Rui-Xin, et al.
Publicado: (2023)

Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
por: Morikawa, Toru, et al.
Publicado: (2022)

Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021
por: Xavier, Andy, et al.
Publicado: (2021)

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
por: Hasegawa, Eriko, et al.
Publicado: (2018)

Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
por: Ward, Leanne M.
Publicado: (2020)

The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020)

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
por: Klop, C., et al.
Publicado: (2013)

The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial
por: Czerwinski, Edward, et al.
Publicado: (2022)

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
por: Yanbeiy, Zeina A, et al.
Publicado: (2019)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people
por: Barnsley, J., et al.
Publicado: (2021)

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
por: Park, So Young, et al.
Publicado: (2018)

The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
por: Zhang, Leiming, et al.
Publicado: (2021)

Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
por: Liang, Haodong, et al.
Publicado: (2023)

Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis
por: Dore, Robin K
Publicado: (2013)

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway: Galangin mitigates glucocorticoid-induced osteoporosis
por: Zeng, Chenying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kbn8apkrofb3e1evco0dg7bcjd